BeiGene PD-1 Tislelizumab Shows Survival Benefit In Esophageal Cancer

 
• By Jessica Merrill
Esophageal Cancer vector
BeiGene's PD-1 inhibitor improved overall survival in esophageal cancer • Source: Shutterstock

More from Anticancer

More from Therapeutic Category